ArticleBMC clinical pharmacology2009
Dispensed drugs and multiple medications in the Swedish population: an individual-based register study.
Article in BMC clinical pharmacology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed, 69 citations in OpenAlex.
- Is tramadol associated to bleeding peptic ulcer? A nationwide case-control study in hospitalized Swedish patients.PloS one · 2019Trial
- Motoric cognitive risk syndrome: prevalence and associated sociodemographic and clinical factors in primary care settings in Brazil.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Article
- Assessing the Impact of Pharmacist-Led Interventions in an Academic Pain Clinic: Clinical Outcomes and Interprofessional Insights.European journal of pain (London, England) · 2025Article
- Unpacking excessive polypharmacy patterns among individuals living with chronic pain in Quebec: a longitudinal study.Frontiers in pain research (Lausanne, Switzerland) · 2025Article
- Characteristics of High-Cost Beneficiaries of Prescription Drugs in Kazakhstan: A Cross-Sectional Study of Outpatient Data from 2022.ClinicoEconomics and outcomes research : CEOR · 2024Article
- Prevalence of polypharmacy in the older adult population within primary care in Portugal: a nationwide cross-sectional study.Archives of medical science : AMS · 2024Article
- Polypharmacy and Excessive Polypharmacy Among Persons Living with Chronic Pain: A Cross-Sectional Study on the Prevalence and Associated Factors.Journal of pain research · 2023Article
- Core concepts in pharmacoepidemiology: Measures of drug utilization based on individual-level drug dispensing data.Pharmacoepidemiology and drug safety · 2022Review
- High-Cost Users of Prescription Drugs: National Health Insurance Data from South Korea.Journal of general internal medicine · 2022Observational
- Feedback of patient survey on medication improves the management of polypharmacy: a pilot trial.BMC family practice · 2021Observational
- Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life.Pharmacology research & perspectives · 2020Article
- Chronic polypharmacy impairs explorative behavior and reduces synaptic functions in young adult mice.Aging · 2020Article
- Fragility fractures in Europe: burden, management and opportunities.Archives of osteoporosis · 2020Article
- An Increasing Trend in the Prevalence of Polypharmacy in Sweden: A Nationwide Register-Based Study.Frontiers in pharmacology · 2020Article
- Prevalence and determinants of polypharmacy in cardiovascular patients attending outpatient clinic in Ethiopia University Hospital.PloS one · 2020Article
- High burden of drug therapy in adult congenital heart disease: polypharmacy as marker of morbidity and mortality.European heart journal. Cardiovascular pharmacotherapy · 2019Article
- Prevalence Of Potentially Inappropriate Medication In The Older Adult Population Within Primary Care In Portugal: A Nationwide Cross-Sectional Study.Patient preference and adherence · 2019Article
- Defining pediatric polypharmacy: A scoping review.PloS one · 2018Article
- Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study.BMC health services research · 2017Article
- Changes in Drug Use and Polypharmacy After the Age of 90: A Longitudinal Study of the Danish 1905 Cohort.Journal of the American Geriatrics Society · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple medications is a well-known potential risk factor in terms of patient's health. The aim of the present study was to estimate the prevalence of dispensed drugs and multiple medications in an entire national population, by using individual based data on dispensed drugs.
methodsAnalyses of all dispensed out-patient prescriptions in 2006 from the Swedish prescribed drug register. As a cut-off for multiple medications, we applied five or more different drugs dispensed (DP >or= 5) at Swedish pharmacies for a single individual during a 3-month, a 6-month, and a 12-month study period. For comparison, results were also calculated with certain drug groups excluded.
results6.2 million individuals received at least one dispensed drug (DP >or= 1) during 12 months in 2006 corresponding to a prevalence of 67.4%; 75.6% for females and 59.3% for males. Individuals received on average 4.7 dispensed drugs per individual (median 3, Q1-Q3 2-6); females 5.0 (median 3, Q1-Q3 2-7), males 4.3 (median 3, Q1-Q3 1-6).The prevalence of multiple medications (DP >or= 5) was 24.4% for the entire population. The prevalence increased with age. For elderly 70-79, 80-89, and 90-years, the prevalence of DP >or= 5 was 62.4, 75.1, and 77.7% in the respective age groups. 82.8% of all individuals with DP >or= 1 and 64.9% of all individuals with DP >or= 5 were < 70 years. Multiple medications was more frequent for females (29.6%) than for males (19.2%). For individuals 10 to 39 years, DP >or= 5 was twice as common among females compared to males. Sex hormones and modulators of the genital system excluded, reduced the relative risk (RR) for females vs. males for DP >or= 5 from 1.5 to 1.4. The prevalence of DP >or= 1 increased from 45.1 to 56.2 and 67.4%, respectively, when the study period was 3, 6, and 12 respectively months and the corresponding prevalence of DP >or= 5 was 11.3, 17.2, and 24.4% respectively.
conclusionThe prevalence of dispensed drugs and multiple medications were extensive in all age groups and were higher for females than for males. Multiple medications should be regarded as a risk in terms of potential drug-drug interactions and adverse drug reactions in all age groups.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.